Herjan Jt Coelingh Bennink

12PUBLICATIONS
35CO-AUTHORS
Obstetrics and gynaecologyBioavailability and ecotoxicologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 07, 2026
A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

Herjan J T Coelingh Bennink, Karolina Afors, Luis Bahamondes

|Jun 30, 2025
The rediscovery of estetrol and its implications for estrogen treatment.

Herjan J T Coelingh Bennink, Roger Gosden, Frank Z Stanczyk

|Oct 16, 2024
Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1.

Herjan J T Coelingh Bennink, Erik P M Roos, R Jeroen A van Moorselaar

|Jul 23, 2024
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth.

Kamila Pulawska-Moon, Donata Ponikwicka-Tyszko, Weronika Lebiedzinska

|Jun 17, 2024
The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.

Herjan J T Coelingh Bennink, Amanda Prowse, Jan F M Egberts

|Mar 01, 2024
Health benefits of combined oral contraceptives - a narrative review.

Herjan J T Coelingh Bennink, Femke A M van Gennip, Mireille G F Gerrits

Pageof 2

Frequent Collaborators

4 joint publications

Jan F M Egberts

2 joint publications

Kristina Gemzell-Danielsson

2 joint publications

Ilpo T Huhtaniemi

2 joint publications

Frank Z Stanczyk